Common use of Eligible Entities Clause in Contracts

Eligible Entities. Exhibits A-1 and A-2 together set forth all entities eligible to participate in this Agreement (“Eligible Entities”): 1. Each entity listed on Exhibit A-1 is either (1) a federally recognized tribe that the U.S. Secretary of the Interior acknowledges as an Indian Tribe, as provided in the Federally Recognized Tribe List Act of 1994, 25 U.S.C. § 5130, and that has filed an opioid case in MDL No. 2804, in federal court outside the MDL, or in State court, or (2) a “tribal organization,” as defined in 25 U.S.C. § 5304(I), or an “inter-tribal consortium,” as defined in 25 U.S.C. § 5381(a)(5), that provides health care pursuant to contracts/compacts with the Indian Health Service, and that has filed an opioid case in MDL No. 2804, in federal court outside the MDL, or in State court. Exhibit A-1 includes the filing docket number and counsel of record for the listed entity. Each entity listed on Exhibit A-1 is entitled to participate in the settlement. 2. Exhibit A-2 includes entities that are federally recognized tribes that the U.S. Secretary of the Interior acknowledges as an Indian Tribe, as provided in the Federally Recognized Tribe List Act of 1994, 25 U.S.C. § 5130, and that have not filed an opioid case in MDL No. 2804, in federal court outside the MDL, or in State court. Exhibit A-2 also includes Alaska Native “tribal organizations,” as defined in 25 U.S.C. § 5304(I) and “inter-tribal consortia,” as defined in 25 U.S.C. § 5381(a)(5), that provide health care pursuant to contracts/compacts with the Indian Health Service, and that have not filed an opioid case in MDL No. 2804, in federal court outside the MDL, or in State court. Each entity listed on Exhibit A-2 is entitled to participate in the settlement.

Eligible Entities. Exhibits A-1 and A-2 together set forth all entities eligible to participate in this Agreement (“Eligible Entities”): 1. Each entity listed on Exhibit A-1 is either (1) a federally recognized tribe that the U.S. Secretary of the Interior acknowledges as an Indian Tribe, as provided in the Federally Recognized Tribe List Act of 1994, 25 U.S.C. § 5130, and that has filed an opioid case against Walmart in MDL No. 2804, 2804 or in federal court outside the MDL, or a case pending in State court, or (2) a “tribal organization,” as defined in 25 U.S.C. § 5304(I), or an “inter-tribal consortium,” as defined in 25 U.S.C. § 5381(a)(5), that provides health care pursuant to contracts/compacts with the Indian Health Service, and that has filed an opioid case against Walmart in MDL No. 2804, 2804 or in federal court outside the MDL, or a case pending in State court. Exhibit A-1 includes the filing docket number and counsel of record for the listed entity. Each entity listed on Exhibit A-1 is entitled to participate in the settlement. Cherokee Nation is excluded from the entities listed on Exhibit A-1 as Cherokee Nation has separately settled with Walmart. 2. Exhibit A-2 includes entities that are federally recognized tribes that the U.S. Secretary of the Interior acknowledges as an Indian Tribe, as provided in the Federally Recognized Tribe List Act of 1994, 25 U.S.C. § 5130, and that have not filed an opioid case against Walmart in MDL No. 2804, 2804 or in federal court outside the MDL, or a case pending in State court. Exhibit A-2 also includes Alaska Native “tribal organizations,” as defined in 25 U.S.C. § 5304(I) and “inter-tribal consortia,” as defined in 25 U.S.C. § 5381(a)(5), that provide health care pursuant to contracts/compacts with the Indian Health Service, and that have not filed an opioid case against Walmart in MDL No. 2804, 2804 or in federal court outside the MDL, or a case pending in State court. Each entity listed on Exhibit A-2 is entitled to participate in the settlement.

Eligible Entities. Exhibits A-1 and A-2 together set forth all entities eligible to 4 participate in this Agreement (“Eligible Entities”): 5 1. Each entity listed on Exhibit A-1 is either (1) a federally recognized tribe 6 that the U.S. Secretary of the Interior acknowledges as an Indian Tribe, as provided in the 7 Federally Recognized Tribe List Act of 1994, 25 U.S.C. § 5130, and that has filed an opioid case 8 against McKinsey in MDL No. 2804, 2996 or in federal court outside the MDL, or a case pending in State court, or (2) a “tribal 9 organization,” as defined in 25 U.S.C. § 5304(I5304(l), or an “inter-tribal consortium,” as defined in 25 10 U.S.C. § 5381(a)(5), that provides health care pursuant to contracts/compacts with the Indian 11 Health Service, and that has filed an opioid case against McKinsey in MDL No. 2804, in federal court outside the MDL, 2996 or in State court. Exhibit A-1 includes the filing docket number and counsel of record for a case 13 the listed entity. Each entity listed on Exhibit A-1 is entitled to participate in the settlement. 14 2. Exhibit A-2 includes entities that are federally recognized tribes that the 15 U.S. Secretary of the Interior acknowledges as an Indian Tribe, as provided in the Federally 16 Recognized Tribe List Act of 1994, 25 U.S.C. § 5130, and that have not filed an opioid case 17 against McKinsey in MDL No. 2804, 2996 or in federal court outside the MDL, or a case pending in State court. Exhibit A-2 also 18 includes Alaska Native “tribal organizations,” as defined in 25 U.S.C. § 5304(I5304(l) and “inter-tribal 19 consortia,” as defined in 25 U.S.C. § 5381(a)(5), that provide health care pursuant to 20 contracts/compacts with the Indian Health Service, and that have not filed an opioid case against 21 McKinsey in MDL No. 2804, 2996 or in federal court outside the MDL, or a case pending in State court. Each entity listed on Exhibit A-2 A- 22 2 is entitled to participate in the settlement.

Eligible Entities. Exhibits A-1 and A-2 together set forth all entities eligible to participate in this Agreement (“Eligible Entities”): 1. Each entity listed on Exhibit A-1 is either (1) a federally recognized tribe that the U.S. Secretary of the Interior acknowledges as an Indian Tribe, as provided in the Federally Recognized Tribe List Act of 1994, 25 U.S.C. § 5130, and that has filed an opioid case against Walgreens in MDL No. 2804, 2804 or in federal court outside the MDL, or a case pending in State court, or (2) a “tribal organization,” as defined in 25 U.S.C. § 5304(I), or an “inter-tribal consortium,” as defined in 25 U.S.C. § 5381(a)(5), that provides health care pursuant to contracts/compacts with the Indian Health Service, and that has filed an opioid case against Walgreens in MDL No. 2804, 2804 or in federal court outside the MDL, or a case pending in State court. Exhibit A-1 includes the filing docket number and counsel of record for the listed entity. Each entity listed on Exhibit A-1 is entitled to participate in the settlement. Cherokee Nation is excluded from the entities listed on Exhibit A-1 as Cherokee Nation has separately settled with Walgreens. 2. Exhibit A-2 includes entities that are federally recognized tribes that the U.S. Secretary of the Interior acknowledges as an Indian Tribe, as provided in the Federally Recognized Tribe List Act of 1994, 25 U.S.C. § 5130, and that have not filed an opioid case against Walgreens in MDL No. 2804, 2804 or in federal court outside the MDL, or a case pending in State court. Exhibit A-2 also includes Alaska Native “tribal organizations,” as defined in 25 U.S.C. § 5304(I) and “inter-tribal consortia,” as defined in 25 U.S.C. § 5381(a)(5), that provide health care pursuant to contracts/compacts with the Indian Health Service, and that have not filed an opioid case against Walgreens in MDL No. 2804, 2804 or in federal court outside the MDL, or a case pending in State court. Each entity listed on Exhibit A-2 is entitled to participate in the settlement.

Eligible Entities. Exhibits A-1 and A-2 together set forth all entities eligible to participate in this Agreement (“Eligible Entities”): 1. Each entity listed on Exhibit A-1 is either (1) a federally recognized tribe that the U.S. Secretary of the Interior acknowledges as an Indian Tribe, as provided in the Federally Recognized Tribe List Act of 1994, 25 U.S.C. § 5130, and that has filed an opioid case against ▇▇▇▇▇▇▇ in MDL No. 2804, 2804 or in federal court outside the MDL, or a case pending in State court, or (2) a “tribal organization,” as defined in 25 U.S.C. § 5304(I), or an “inter-tribal consortium,” as defined in 25 U.S.C. § 5381(a)(5), that provides health care pursuant to contracts/compacts with the Indian Health Service, and that has filed an opioid case against ▇▇▇▇▇▇▇ in MDL No. 2804, 2804 or in federal court outside the MDL, or a case pending in State court. Exhibit A-1 includes the filing docket number and counsel of record for the listed entity. Each entity listed on Exhibit A-1 is entitled to participate in the settlement. 2. Exhibit A-2 includes entities that are federally recognized tribes that the U.S. Secretary of the Interior acknowledges as an Indian Tribe, as provided in the Federally Recognized Tribe List Act of 1994, 25 U.S.C. § 5130, and that have not filed an opioid case against ▇▇▇▇▇▇▇ in MDL No. 2804, 2804 or in federal court outside the MDL, or a case pending in State court. Exhibit A-2 also includes Alaska Native “tribal organizations,” as defined in 25 U.S.C. § 5304(I) and “inter-tribal consortia,” as defined in 25 U.S.C. § 5381(a)(5), that provide health care pursuant to contracts/compacts with the Indian Health Service, and that have not filed an opioid case against ▇▇▇▇▇▇▇ in MDL No. 2804, 2804 or in federal court outside the MDL, or a case pending in State court. Each entity listed on Exhibit A-2 is entitled to participate in the settlement.

Eligible Entities. Exhibits A-1 and A-2 together set forth all entities eligible to participate in this Agreement (“Eligible Entities”): 1. Each entity listed on Exhibit A-1 is either (1) a federally recognized tribe that the U.S. Secretary of the Interior acknowledges as an Indian Tribe, as provided in the Federally Recognized Tribe List Act of 1994, 25 U.S.C. § 5130, and that has filed an opioid case in MDL No. 2804, 2804 or in federal court outside the MDL, or a case pending in State court, or (2) a “tribal organization,” as defined in 25 U.S.C. § 5304(I), or an “inter-tribal consortium,” as defined in 25 U.S.C. § 5381(a)(5), that provides health care pursuant to contracts/compacts with the Indian Health Service, and that has filed an opioid case against CVS in MDL No. 2804, 2804 or in federal court outside the MDL, or a case pending in State court. Exhibit A-1 includes the filing docket number and counsel of record for the listed entity. Each entity listed on Exhibit A-1 is entitled to participate in this Agreement. Cherokee Nation is excluded from the settlemententities listed on Exhibit A-1 as Cherokee Nation has separately settled with CVS. 2. Exhibit A-2 includes entities that are federally recognized tribes that the U.S. Secretary of the Interior acknowledges as an Indian Tribe, as provided in the Federally Recognized Tribe List Act of 1994, 25 U.S.C. § 5130, and that have not filed an opioid case in MDL No. 2804, 2804 or in federal court outside the MDL, or a case pending in State court. Exhibit A-2 also includes Alaska Native “tribal organizations,” as defined in 25 U.S.C. § 5304(I) and “inter-tribal consortia,” as defined in 25 U.S.C. § 5381(a)(5), that provide health care pursuant to contracts/compacts with the Indian Health Service, and that have not filed an opioid case in MDL No. 2804, in federal court outside the MDL, or in State court. Each entity listed on Exhibit A-2 is entitled to participate in the settlement.in